{"id":"ocular-lubricant","brandName":"Ocular lubricant","genericName":"Ocular lubricant","companyId":"ophthalmic-consultants-of-long-island","companyName":"Ophthalmic Consultants of Long Island","phase":"marketed","status":"active","modality":"Small molecule","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Ocular lubricant is a marketed topical ophthalmic formulation developed by Ophthalmic Consultants of Long Island for the treatment of dry eye disease and related ocular surface conditions. The product functions as a lubricating agent that restores the tear film and provides symptomatic relief through hydration and protection of the corneal and conjunctival surfaces. Currently in the marketed phase with no active FDA label data available, the drug has been evaluated across 50 clinical trials spanning Phase 1 through Phase 4, with particular focus on dry eye syndrome efficacy and safety. Key clinical differentiation emerges from comparative studies against established lubricants (Artelac® Nighttime Gel) and emerging formulations (nanoemulsions, sodium hyaluronate variants), demonstrating tolerability and efficacy in diverse patient populations including pediatric and geriatric cohorts. The ocular lubricant market represents a substantial commercial opportunity within the broader dry eye disease segment, with multiple formulation variants and delivery mechanisms under investigation. Pipeline expansion includes novel delivery systems and combination therapies with anti-inflammatory agents, positioning the product within a competitive landscape dominated by established players and emerging biotechnology innovators.","enrichmentLevel":3,"visitCount":0,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ocular lubricants work by supplementing natural tear film, which is essential for maintaining corneal health, comfort, and clarity of vision. They reduce evaporation of tears, protect the epithelial surface from mechanical irritation, and provide lubrication to allow smooth eyelid movement. These products are typically composed of viscous agents such as carboxymethylcellulose, hyaluronic acid, or mineral oil that mimic the properties of natural tears.","oneSentence":"Ocular lubricants reduce friction and provide moisture to the ocular surface by forming a protective film over the cornea and conjunctiva.","_ai_confidence":"high"},"administration":{},"safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation or stinging"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"trials":[],"indications":{"approved":[{"name":"Dry eye syndrome / Keratoconjunctivitis sicca"},{"name":"Ocular surface irritation and discomfort"}]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":["Dry Eye Disease"],"enrollment":80,"completionDate":"2025-03-21"},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":["Recurrent Ovarian Cancer","Folate Receptor-Alpha Positive"],"enrollment":100,"completionDate":"2027-06"},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":["Trachomatous Trichiasis (TT)","Eye Diseases","Eyelid Diseases","Trachomatous","Trichiasis"],"enrollment":2410,"completionDate":"2024-11-30"},{"nctId":"NCT05577910","phase":"NA","title":"Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-08","conditions":["Meibomian Gland Dysfunction"],"enrollment":374,"completionDate":"2025-01-26"},{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":["Dry Eye Syndromes"],"enrollment":200,"completionDate":"2025-06-22"},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":["Dry Eye Disease"],"enrollment":55,"completionDate":"2025-02-06"},{"nctId":"NCT06792903","phase":"EARLY_PHASE1","title":"YM-101 Eye Drops in the Treatment of Dry Eye Syndrome","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-04-23","conditions":["Dry Eye"],"enrollment":30,"completionDate":"2025-05-15"},{"nctId":"NCT07238699","phase":"NA","title":"An Evaluation of the Safety and Tolerability of Ocular Lubricants","status":"RECRUITING","sponsor":"Alcon Research","startDate":"2026-03-04","conditions":["Dry Eye Disease"],"enrollment":148,"completionDate":"2026-08"},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":["Dry Eye","Insulin"],"enrollment":116,"completionDate":"2025-11-05"},{"nctId":"NCT07451184","phase":"PHASE4","title":"Comparison of Ocular Lubricants in People With Symptoms of Dry Eye","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2026-02-23","conditions":["Dry Eye Symptoms"],"enrollment":100,"completionDate":"2027-05-23"},{"nctId":"NCT06444516","phase":"NA","title":"Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-09-04","conditions":["Dry Eye Disease"],"enrollment":188,"completionDate":"2025-02-07"},{"nctId":"NCT07372014","phase":"PHASE4","title":"A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treatment of Epiphora Associated With Lacrimal Punctum Stenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2026-01-12","conditions":["Epiphora","Punctal Stenosis"],"enrollment":68,"completionDate":"2026-05-29"},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":["Dry Eye Syndromes"],"enrollment":32,"completionDate":"2024-06-26"},{"nctId":"NCT07229001","phase":"NA","title":"Treating Meibomian Gland Disease in a Pediatric Population","status":"ENROLLING_BY_INVITATION","sponsor":"Illinois College of Optometry","startDate":"2024-10-01","conditions":["Dry Eye Disease, Meibomian Gland Disease"],"enrollment":15,"completionDate":"2026-12-30"},{"nctId":"NCT07078955","phase":"PHASE2","title":"A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"BRIM Biotechnology Inc.","startDate":"2025-12","conditions":["Dry Eye Disease (DED)","Keratoconjunctivitis Sicca"],"enrollment":99,"completionDate":"2027-03"},{"nctId":"NCT06876077","phase":"NA","title":"Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-03-15","conditions":["Dry Eye Symptoms"],"enrollment":50,"completionDate":"2025-08-31"},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":["Dry Eye","Acupuncture"],"enrollment":90,"completionDate":"2025-08-01"},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":["Dry Eye"],"enrollment":36,"completionDate":"2025-07-31"},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":["Age-Related Macular Degeneration"],"enrollment":64,"completionDate":"2025-05-01"},{"nctId":"NCT05938699","phase":"PHASE2,PHASE3","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2023-12-12","conditions":["Open Angle Glaucoma"],"enrollment":18,"completionDate":"2025-03-17"},{"nctId":"NCT05902364","phase":"NA","title":"Systane® Ultra Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-28","conditions":["Dry Eye"],"enrollment":69,"completionDate":"2024-08-14"},{"nctId":"NCT06571656","phase":"NA","title":"Evaluation of the Safety and Tolerability of Ocular Lubricants","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2025-04-02","conditions":["Dry Eye Disease"],"enrollment":73,"completionDate":"2025-07-11"},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":["Diabetic Eye Problems"],"enrollment":99,"completionDate":"2023-06-30"},{"nctId":"NCT06865144","phase":"PHASE4","title":"Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT","status":"RECRUITING","sponsor":"East Coast Institute for Research","startDate":"2025-06-27","conditions":["Primary Open Angle Glaucoma or Ocular Hypertension"],"enrollment":70,"completionDate":"2026-04-01"},{"nctId":"NCT05896670","phase":"PHASE2","title":"Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Oculis","startDate":"2023-11-29","conditions":["Dry Eye Disease"],"enrollment":122,"completionDate":"2024-03-27"},{"nctId":"NCT07000565","phase":"NA","title":"The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-11-01","conditions":["Ocular Surface Disease"],"enrollment":42,"completionDate":"2025-01-01"},{"nctId":"NCT03368404","phase":"NA","title":"A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye","status":"COMPLETED","sponsor":"Laboratoire Chauvin","startDate":"2017-11-09","conditions":["Dry Eye"],"enrollment":92,"completionDate":"2020-06-02"},{"nctId":"NCT06939959","phase":"PHASE4","title":"Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-04-14","conditions":["Dry Eye","Insulin Sensitivity"],"enrollment":126,"completionDate":"2026-04-20"},{"nctId":"NCT06921525","phase":"PHASE1,PHASE2","title":"Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Ehab Mohamed Elsayed Mohamed Saad","startDate":"2025-04-01","conditions":["Dry Eye"],"enrollment":44,"completionDate":"2025-08-01"},{"nctId":"NCT06913556","phase":"NA","title":"Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":["Dry Eye Syndrome"],"enrollment":64,"completionDate":"2026-02-20"},{"nctId":"NCT05932225","phase":"NA","title":"Systane® Complete Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-08-18","conditions":["Dry Eye"],"enrollment":71,"completionDate":"2024-02-20"},{"nctId":"NCT01207752","phase":"NA","title":"The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2010-09","conditions":["Meibomian Gland Dysfunction"],"enrollment":69,"completionDate":"2011-07"},{"nctId":"NCT05705518","phase":"PHASE4","title":"Artificial Tears, Tear Lipids and Tear Film Dynamics","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2023-01-30","conditions":["Dry Eye"],"enrollment":81,"completionDate":"2024-01-30"},{"nctId":"NCT05832996","phase":"PHASE4","title":"Cool vs Room-temperature Artificial Tears","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2022-03-01","conditions":["Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)","Central Retinal Vein Occlusion With Macular Edema","Exudative Age-Related Macular Degeneration, Unspecified Eye","Cystoid Macular Edema","Ocular Surface Disease","Dry Eye Sensation","Eye Pain"],"enrollment":124,"completionDate":"2022-07-06"},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":["Dry Eye"],"enrollment":45,"completionDate":"2023-02-03"},{"nctId":"NCT06174181","phase":"NA","title":"Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2023-10-09","conditions":["Dry Eye Syndromes","Age-Related Macular Degeneration"],"enrollment":42,"completionDate":"2024-11-14"},{"nctId":"NCT06752278","phase":"NA","title":"Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-01","conditions":["Dry Eye Disease (DED)"],"enrollment":40,"completionDate":"2024-12-20"},{"nctId":"NCT06745089","phase":"NA","title":"Treatment Effect of Intense Pulsed Light and Thermal Pulsation Therapy on Meibomian Gland Dysfunction-associated Dry Eye Disease: a Randomized Trial","status":"COMPLETED","sponsor":"National Yang Ming Chiao Tung University","startDate":"2022-07-13","conditions":["Dry Eye Disease (DED)","Meibomian Gland Dysfunction"],"enrollment":45,"completionDate":"2024-03-10"},{"nctId":"NCT03031327","phase":"NA","title":"Safety and Efficacy of 2 Concentrations of Lubricin vs Sodium Hyaluronate in Ocular Discomfort After Refractive Surgery.","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2017-06-17","conditions":["Ocular Discomfort"],"enrollment":30,"completionDate":"2017-08-10"},{"nctId":"NCT06720428","phase":"NA","title":"Acupoint Therapy Device for Dry Eye","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-01-01","conditions":["Dry Eye"],"enrollment":120,"completionDate":"2024-05-31"},{"nctId":"NCT06188260","phase":"PHASE2","title":"Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-01-16","conditions":["Dry Eye Syndromes"],"enrollment":31,"completionDate":"2024-11-04"},{"nctId":"NCT06686368","phase":"PHASE4","title":"Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"I-MED Pharma","startDate":"2024-11-15","conditions":["Evaporative Dry Eye Disease"],"enrollment":60,"completionDate":"2025-03-31"},{"nctId":"NCT05887336","phase":"NA","title":"Intra-Nasal Mechanical Stimulation (INMEST) As a Treatment Method for the Relief of Symptoms of Dry Eye","status":"COMPLETED","sponsor":"Abilion Medical Systems AB","startDate":"2023-06-01","conditions":["Dry Eye","Dry Eye Syndromes"],"enrollment":106,"completionDate":"2024-10-31"},{"nctId":"NCT06017362","phase":"PHASE4","title":"Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors","status":"RECRUITING","sponsor":"Barbara Burgos Blasco","startDate":"2023-02-08","conditions":["Dry Eye","Glaucoma"],"enrollment":100,"completionDate":"2026-02-08"},{"nctId":"NCT03374306","phase":"NA","title":"Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2018-02-01","conditions":["Myopia"],"enrollment":71,"completionDate":"2020-08-31"},{"nctId":"NCT05878067","phase":"PHASE3","title":"A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-06-27","conditions":["Dry Eye Syndrome"],"enrollment":40,"completionDate":"2023-10-06"},{"nctId":"NCT04630158","phase":"PHASE2","title":"Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-04-21","conditions":["Chronic Ocular Pain"],"enrollment":153,"completionDate":"2023-06-08"},{"nctId":"NCT04118920","phase":"PHASE1","title":"Safety of Topical Insulin Drops for Open-angle Glaucoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-03-27","conditions":["Glaucoma"],"enrollment":18,"completionDate":"2024-12"},{"nctId":"NCT02120079","phase":"PHASE4","title":"The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2014-02","conditions":["Dry Eye Disease"],"enrollment":37,"completionDate":"2018-01-28"},{"nctId":"NCT06461975","phase":"PHASE3","title":"Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-01","conditions":["Retinopathy of Prematurity"],"enrollment":88,"completionDate":"2023-06-01"},{"nctId":"NCT00801905","phase":"PHASE2","title":"Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation","status":"TERMINATED","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2008-08","conditions":["Macular Thickening","Macular Edema"],"enrollment":50,"completionDate":"2009-03"},{"nctId":"NCT03653650","phase":"NA","title":"Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2018-08-30","conditions":["Persistent Epithelial Defect"],"enrollment":54,"completionDate":"2025-08"},{"nctId":"NCT06358456","phase":"NA","title":"Influence of Artificial Tears on Keratometry and Biometry Measurements With Different Devices","status":"COMPLETED","sponsor":"University Clinic Frankfurt","startDate":"2020-11-20","conditions":["Healthy"],"enrollment":145,"completionDate":"2022-04-22"},{"nctId":"NCT03813056","phase":"PHASE2","title":"Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy","status":"RECRUITING","sponsor":"Michael D. Straiko, MD","startDate":"2019-03-25","conditions":["Fuchs Endothelial Dystrophy"],"enrollment":72,"completionDate":"2025-02-01"},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":["Dry Eye Syndromes"],"enrollment":40,"completionDate":"2024-12"},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":["Dry Eye Disease","Cataract"],"enrollment":70,"completionDate":"2023-07-05"},{"nctId":"NCT04327999","phase":"PHASE2","title":"Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2020-10-05","conditions":["Thyroid Carcinoma","Radioactive Iodine Level"],"enrollment":9,"completionDate":"2023-09-25"},{"nctId":"NCT04515329","phase":"PHASE4","title":"Tear Film Markers in Dry Eye Syndrome","status":"WITHDRAWN","sponsor":"Vishal Jhanji","startDate":"2023-12-08","conditions":["Dry Eye"],"enrollment":0,"completionDate":"2023-12-08"},{"nctId":"NCT06162442","phase":"","title":"Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye","status":"UNKNOWN","sponsor":"Tecnoquimicas","startDate":"2023-03-15","conditions":["Dry Eye Disease"],"enrollment":132,"completionDate":"2024-04-15"},{"nctId":"NCT01144494","phase":"EARLY_PHASE1","title":"Aqueous Humor Dynamics and Brimonidine","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2010-08-01","conditions":["Intraocular Pressure"],"enrollment":35,"completionDate":"2011-10-01"},{"nctId":"NCT06122428","phase":"","title":"Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease","status":"COMPLETED","sponsor":"University of Naples","startDate":"2022-02-08","conditions":["Dry Eye Disease"],"enrollment":16,"completionDate":"2022-10-10"},{"nctId":"NCT05888519","phase":"NA","title":"Evaluation of Safety and Tolerability of Investigational Ocular Lubricants","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-07-24","conditions":["Dry Eye Disease"],"enrollment":47,"completionDate":"2023-09-27"},{"nctId":"NCT05741216","phase":"NA","title":"Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-05-01","conditions":["Dry Eye"],"enrollment":36,"completionDate":"2023-10-02"},{"nctId":"NCT04465071","phase":"NA","title":"Lubricating Eye Drops After Routine Cataract Surgery","status":"COMPLETED","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2020-02-24","conditions":["Dry Eye","Cataract"],"enrollment":79,"completionDate":"2022-08-31"},{"nctId":"NCT05618730","phase":"PHASE1","title":"Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B","status":"UNKNOWN","sponsor":"Eximore Ltd.","startDate":"2022-09-29","conditions":["Dry Eye","Keratoconjunctivitis Sicca","Ocular Inflammation"],"enrollment":20,"completionDate":"2023-12-30"},{"nctId":"NCT05660681","phase":"NA","title":"Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops","status":"COMPLETED","sponsor":"Calm Water Therapeutics LLC","startDate":"2022-12-12","conditions":["Dry Eye Disease"],"enrollment":34,"completionDate":"2023-08-15"},{"nctId":"NCT00836485","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Senju USA, Inc.","startDate":"2009-02","conditions":["Allergic Conjunctivitis"],"enrollment":122,"completionDate":"2009-03"},{"nctId":"NCT05940376","phase":"","title":"Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy","status":"UNKNOWN","sponsor":"Benha University","startDate":"2023-07-15","conditions":["Corneal Ulcer","Neurotrophic Corneal Ulcer","Diabetes Mellitus"],"enrollment":30,"completionDate":"2023-08-15"},{"nctId":"NCT05573360","phase":"NA","title":"Evaluation of Safety and Tolerability of Ocular Lubricants","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2022-12-16","conditions":["Dry Eye"],"enrollment":41,"completionDate":"2023-05-31"},{"nctId":"NCT04343222","phase":"PHASE4","title":"Control of Pain in Intravitreal Injections Using Topical NSAIDs","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-06-27","conditions":["Intravitreal Injections","IVI"],"enrollment":46,"completionDate":"2019-12-19"},{"nctId":"NCT02623023","phase":"NA","title":"Prophylaxis for Anti-VEGF-induced IOP Elevation","status":"WITHDRAWN","sponsor":"McMaster University","startDate":"2019-01-01","conditions":["Ocular Hypertension"],"enrollment":0,"completionDate":"2019-01-01"},{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":["Dry Eye Syndromes"],"enrollment":80,"completionDate":"2022-07-01"},{"nctId":"NCT05056233","phase":"NA","title":"Systane Hydration in Subjects Undergoing Cataract Surgery","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2022-01-18","conditions":["Dry Eye Disease","Cataract"],"enrollment":35,"completionDate":"2023-01-12"},{"nctId":"NCT05553561","phase":"NA","title":"Intense Regulated Pulse Light Therapy in Dry Eye Disease","status":"UNKNOWN","sponsor":"Menoufia University","startDate":"2023-01-01","conditions":["Dry Eye Disease"],"enrollment":34,"completionDate":"2023-12"},{"nctId":"NCT04980144","phase":"NA","title":"Diquafosol Ophthalmic Solution for Dry Eye Symptoms","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-03-03","conditions":["Diabetic Eye Problems"],"enrollment":101,"completionDate":"2023-11-01"},{"nctId":"NCT04668131","phase":"NA","title":"Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2020-09-22","conditions":["Dry Eye"],"enrollment":20,"completionDate":"2022-06-30"},{"nctId":"NCT01375582","phase":"EARLY_PHASE1","title":"Objective Evaluation of Ocular Surface Lubricants in Two Environments","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2011-06","conditions":["Dry Eye"],"enrollment":20,"completionDate":"2012-06"},{"nctId":"NCT05255016","phase":"PHASE2,PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":["Keratitis","Corneal Ulcer"],"enrollment":488,"completionDate":"2024-02-24"},{"nctId":"NCT05255107","phase":"PHASE2,PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":["Keratitis","Corneal Ulcer"],"enrollment":468,"completionDate":"2024-02-24"},{"nctId":"NCT05307081","phase":"","title":"An Observational, Qualitative Study Assessing Eye Drop Administration","status":"UNKNOWN","sponsor":"Ocular Therapeutix, Inc.","startDate":"2022-04-21","conditions":["Ocular Injury"],"enrollment":300,"completionDate":"2023-12"},{"nctId":"NCT05536661","phase":"NA","title":"Impact of Tear Substitute Use on Dry Eye in Gamers.","status":"COMPLETED","sponsor":"Laboratorios Thea, Spain","startDate":"2019-07-04","conditions":["Evaporative Dry Eye"],"enrollment":56,"completionDate":"2019-07-07"},{"nctId":"NCT04193774","phase":"NA","title":"Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-08-19","conditions":["Microbiota","Ocular Surface"],"enrollment":24,"completionDate":"2021-12-31"},{"nctId":"NCT03591874","phase":"PHASE3","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease","status":"TERMINATED","sponsor":"Ocugen","startDate":"2018-12-23","conditions":["Graft Versus Host Disease","Ocular Surface Disease","oGVHD","Ocular Graft vs Host Disease","Brimonidine Tartrate","Lubricant Eye Drops","Ophthalmic Solutions","Graft vs Host Disease"],"enrollment":59,"completionDate":"2020-04-30"},{"nctId":"NCT05433428","phase":"PHASE4","title":"Metabolomic Profile in Dry Eye Syndrome Patients.","status":"UNKNOWN","sponsor":"Ifocus Oyeklinikk","startDate":"2020-08-03","conditions":["Dry Eye Syndromes","Cataract"],"enrollment":250,"completionDate":"2023-05-23"},{"nctId":"NCT05425914","phase":"PHASE3","title":"Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level","status":"COMPLETED","sponsor":"University of Faisalabad","startDate":"2021-11-01","conditions":["Dry Eye Syndromes","Hypovitaminosis D"],"enrollment":108,"completionDate":"2022-04-30"},{"nctId":"NCT05056155","phase":"NA","title":"Systane Complete Multi-symptom Relief","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2021-11-09","conditions":["Dry Eye Disease"],"enrollment":119,"completionDate":"2022-03-25"},{"nctId":"NCT04830956","phase":"NA","title":"Evaluation of Comfort in Subjects With Moderate Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2021-06-30","conditions":["Dry Eye"],"enrollment":40,"completionDate":"2021-11-10"},{"nctId":"NCT04963543","phase":"NA","title":"Evaluation of Comfort in Symptomatic Contact Lens Wearers","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2021-07-22","conditions":["Ocular Comfort"],"enrollment":17,"completionDate":"2021-10-29"},{"nctId":"NCT05083689","phase":"PHASE2,PHASE3","title":"Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2021-10-06","conditions":["Diabetic Macular Edema"],"enrollment":62,"completionDate":"2022-04"},{"nctId":"NCT04081610","phase":"PHASE1","title":"Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2019-09-09","conditions":["Dry Eye"],"enrollment":34,"completionDate":"2019-11-13"},{"nctId":"NCT04868175","phase":"NA","title":"Interval Intraocular Pressure in Intravitreal Injection Study","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2019-10-01","conditions":["Glaucoma","Intraocular Pressure"],"enrollment":64,"completionDate":"2021-04-01"},{"nctId":"NCT04843839","phase":"PHASE2","title":"CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2020-12-15","conditions":["Congenital Hereditary Endothelial Dystrophy of Cornea"],"enrollment":30,"completionDate":"2022-12-15"},{"nctId":"NCT03380624","phase":"PHASE4","title":"Tear Lipid Layer Thickness With Emollient Eye Drops","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2017-03-01","conditions":["Dry Eye Syndromes"],"enrollment":21,"completionDate":"2018-06-30"},{"nctId":"NCT02472223","phase":"NA","title":"Reducing Adenoviral Patient Infected Days","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-03-23","conditions":["Conjunctivitis","Adenoviral Conjunctivitis"],"enrollment":28,"completionDate":"2018-06-01"},{"nctId":"NCT00397241","phase":"PHASE4","title":"24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2006-09","conditions":["Open-angle Glaucoma"],"enrollment":33,"completionDate":"2007-12"},{"nctId":"NCT01267656","phase":"NA","title":"Study to Evaluate a Contact Lens Lubricating and Rewetting Drop","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2010-10","conditions":["Dry Eye"],"enrollment":168,"completionDate":"2010-12"},{"nctId":"NCT02004067","phase":"PHASE4","title":"Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2013-01","conditions":["Primary Sjogren Syndrome","Secondary Sjogren Syndrome","Aqueous Deficient Dry Eye Disease","Evaporative Dry Eye Disease"],"enrollment":100,"completionDate":"2016-08"},{"nctId":"NCT04217785","phase":"PHASE1,PHASE2","title":"Umbilical Cord Serum Versus Conventional Eyedrops","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2020-01-20","conditions":["Dry Eye Syndromes"],"enrollment":102,"completionDate":"2021-05"},{"nctId":"NCT00689078","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2008-05","conditions":["Allergic Conjunctivitis"],"enrollment":36,"completionDate":"2008-06"},{"nctId":"NCT02845336","phase":"PHASE2","title":"Celecoxib for Thyroid Eye Disease","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2017-03-05","conditions":["Thyroid Eye Disease"],"enrollment":7,"completionDate":"2019-06-30"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}